Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds

被引:26
作者
Heldner, Mirjam R. [1 ]
Li, Linxin [1 ]
Lovett, Nicola G. [1 ]
Kubiak, Magdalena M. [1 ]
Lyons, Shane [1 ]
Rothwell, Peter M. [1 ]
机构
[1] Univ Oxford, Nuffield Dept Clin Neurosci, Ctr Prevent Stroke & Dementia, Oxford, England
基金
英国惠康基金; 瑞士国家科学基金会;
关键词
atherosclerosis; coronary artery disease; peripheral vascular disease; prognosis; stroke; CARDIOVASCULAR EVENT RATES; WRITING GROUP; RISK; METAANALYSIS; CORONARY; OUTPATIENTS; PREVENTION; DEATH;
D O I
10.1161/STROKEAHA.118.020913
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose Cerebrovascular, coronary, and peripheral vascular disease have common underlying arterial pathology and risk factors, but the clinical significance of multiple-territory disease in patients with transient ischemic attack (TIA)/ischemic stroke is unclear, particularly whether the number of clinically affected territories still predicts long-term outcome on current standard secondary prevention therapies. Methods In a population-based study of 92728 individuals in Oxfordshire, United Kingdom (Oxford Vascular Study), we studied patients presenting with TIA/ischemic stroke (2002-2014) in relation to the number of other vascular beds (coronary, peripheral) affected by symptomatic (current or previous) disease. We compared the risk factor profile and long-term prognosis in patients with single- versus multiple-territory disease. Results Among 2554 patients with 10679 patient-years of follow-up, 1842 (72.1%) had single- (TIA/stroke only), 608 (23.8%) double-, and 104 (4.1%) triple-territory symptomatic vascular disease. The number of affected vascular beds increased with the number of atherosclerotic risk factors (P-trend<0.0001). Compared with patients with TIA/stroke only, those with multiple-territory disease had more hypertension (age/sex-adjusted odds ratio [OR], 3.43; 95% confidence interval [CI], 2.76-4.27; P<0.0001), diabetes mellitus (OR, 2.89; 95% CI, 2.27-3.66; P<0.0001), hypercholesterolemia (OR, 4.67; 95% CI, 3.85-5.66; P<0.0001), and current or previous smoking (OR, 1.52; 95% CI, 1.26-1.84; P<0.0001). Triple-territory disease was particularly strongly associated with hypercholesterolemia (OR, 6.80; 95% CI, 4.39-10.53; P<0.0001). Despite more intensive secondary prevention in patients with multiple-territory disease, the 5-year risk of vascular death increased steeply with the number of territories affected (17.2% versus 30.0% versus 42.9%; P<0.0001). Compared with patients with single-territory, patients with multiple-territory disease also had higher postacute long-term risks (90 days to 10 years) of recurrent ischemic stroke (age/sex-adjusted hazard ratio, 1.38; 95% CI, 1.04-1.81; P=0.02) and nonstroke acute vascular events (hazard ratio, 3.06; 95% CI, 2.23-4.20; P<0.0001). Conclusions Number of affected vascular beds appeared to be a simple clinical rule in identifying TIA/ischemic stroke patients who are at high long-term risk of nonstroke vascular events and vascular death.
引用
收藏
页码:1639 / 1646
页数:8
相关论文
共 26 条
  • [11] Atherosclerotic vascular disease conference - Executive summary - Atherosclerotic vascular disease conference proceeding for healthcare professionals from a special writing group of the American Heart Association
    Faxon, DP
    Creager, MA
    Smith, SC
    Pasternak, RC
    Olin, JW
    Bettmann, MA
    Criqui, MH
    Milani, RV
    Loscalzo, J
    Kaufman, JA
    Jones, DW
    Pearce, WH
    [J]. CIRCULATION, 2004, 109 (21) : 2595 - 2604
  • [12] Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
    Bowman L.
    Hopewell J.C.
    Chen F.
    Wallendszus K.
    Stevens W.
    Collins R.
    Wiviott S.D.
    Cannon C.P.
    Braunwald E.
    Sammons E.
    Landray M.J.
    Jiang L.
    Armitage J.
    Haynes R.
    Maggioni A.P.
    Angermann C.E.
    Ertl G.
    Wanner C.
    Pedersen T.
    Goto S.
    Teramoto T.
    Baigent C.
    Barter P.
    Chen Y.
    Chen Z.
    Gray A.
    Mihaylova B.
    Sleight P.
    Tobert J.
    Blaustein R.
    DeLucca P.
    Mitchel Y.
    van Leijenhorst G.
    Sandercock P.
    DeMets D.
    Kjekshus J.
    Neuberger J.
    Tonkin A.
    Emberson J.
    Granger C.
    Colhoun H.
    Barton J.
    Bray C.
    Dayanandan R.
    Knott C.
    Lay M.
    Murphy K.
    Wincott E.
    Achiri P.
    Barry S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13) : 1217 - 1227
  • [13] Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: Insights from the Framingham Study
    Kannel W.B.
    Wolf P.A.
    [J]. Current Atherosclerosis Reports, 2006, 8 (4) : 317 - 323
  • [14] Progress and challenges in translating the biology of atherosclerosis
    Libby, Peter
    Ridker, Paul M.
    Hansson, Goran K.
    [J]. NATURE, 2011, 473 (7347) : 317 - 325
  • [15] Qizilbash N, 1995, LANCET, V346, P1647
  • [16] Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
    Ridker, P. M.
    Everett, B. M.
    Thuren, T.
    MacFadyen, J. G.
    Chang, W. H.
    Ballantyne, C.
    Fonseca, F.
    Nicolau, J.
    Koenig, W.
    Anker, S. D.
    Kastelein, J. J. P.
    Cornel, J. H.
    Pais, P.
    Pella, D.
    Genest, J.
    Cifkova, R.
    Lorenzatti, A.
    Forster, T.
    Kobalava, Z.
    Vida-Simiti, L.
    Flather, M.
    Shimokawa, H.
    Ogawa, H.
    Dellborg, M.
    Rossi, P. R. F.
    Troquay, R. P. T.
    Libby, P.
    Glynn, R. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (12) : 1119 - 1131
  • [17] Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)
    Rothwell, PM
    Coull, AJ
    Giles, MF
    Howard, SC
    Silver, LE
    Bull, LM
    Gutnikov, SA
    Edwards, P
    Mant, D
    Sackley, CM
    Farmer, A
    Sandercock, PAG
    Dennis, MS
    Warlow, CP
    Bamford, JM
    Anslow, P
    [J]. LANCET, 2004, 363 (9425) : 1925 - 1933
  • [18] Carotid artery disease and the risk of ischaemic stroke and coronary vascular events
    Rothwell, PM
    [J]. CEREBROVASCULAR DISEASES, 2000, 10 : 21 - 33
  • [19] Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]
  • [20] Atherosclerotic vascular disease conference - Writing group II: Risk factors
    Smith, SC
    Milani, RV
    Arnett, DK
    Crouse, JR
    McDermott, MM
    Ridker, PM
    Rosenson, RS
    Taubert, KA
    Wilson, PWF
    [J]. CIRCULATION, 2004, 109 (21) : 2613 - 2616